Primary |
Drug Use For Unknown Indication |
22.7% |
Depression |
18.2% |
Pain |
10.4% |
Completed Suicide |
7.8% |
Headache |
7.8% |
Product Used For Unknown Indication |
7.1% |
Migraine |
4.5% |
Neuralgia |
3.2% |
Pain Management |
2.6% |
Drug Abuser |
1.9% |
Muscle Spasms |
1.9% |
Panic Disorder |
1.9% |
Sleep Disorder |
1.9% |
Insomnia |
1.3% |
Maternal Drugs Affecting Foetus |
1.3% |
Psychotic Disorder |
1.3% |
Respiratory Distress |
1.3% |
Thrombosis Prophylaxis |
1.3% |
Arthritis |
0.6% |
Attention Deficit/hyperactivity Disorder |
0.6% |
|
Completed Suicide |
11.8% |
Insomnia |
7.8% |
Syncope |
7.8% |
Death |
5.9% |
Pain In Extremity |
5.9% |
Premature Baby |
5.9% |
Suicidal Ideation |
5.9% |
Toxicity To Various Agents |
5.9% |
Amnesia |
3.9% |
Hypotension |
3.9% |
Long Qt Syndrome |
3.9% |
Mental Disorder |
3.9% |
Paraesthesia |
3.9% |
Product Quality Issue |
3.9% |
Product Substitution Issue |
3.9% |
Sedation |
3.9% |
Serotonin Syndrome |
3.9% |
White Blood Cell Count Increased |
3.9% |
Abdominal Discomfort |
2.0% |
Affect Lability |
2.0% |
|
Secondary |
Drug Use For Unknown Indication |
30.0% |
Product Used For Unknown Indication |
18.2% |
Depression |
10.8% |
Pain |
8.1% |
Post-thoracotomy Pain Syndrome |
4.1% |
Anxiety |
3.6% |
Insomnia |
3.0% |
Headache |
2.8% |
Hypertension |
2.7% |
Migraine |
2.6% |
Neuralgia |
2.2% |
Psychotic Disorder |
1.9% |
Suicide Attempt |
1.8% |
Ill-defined Disorder |
1.5% |
Neck Pain |
1.5% |
Neuropathy Peripheral |
1.2% |
Obsessive-compulsive Disorder |
1.0% |
Prophylaxis |
1.0% |
Bipolar Disorder |
0.9% |
Epilepsy |
0.9% |
|
Completed Suicide |
17.2% |
Toxicity To Various Agents |
12.7% |
Drug Toxicity |
9.5% |
Respiratory Arrest |
5.4% |
Weight Increased |
5.4% |
Weight Decreased |
5.0% |
Intentional Overdose |
4.5% |
Suicidal Ideation |
4.1% |
Cardiac Failure |
3.6% |
Constipation |
3.6% |
Overdose |
3.6% |
Multiple Drug Overdose |
3.2% |
Premature Ageing |
3.2% |
Suicide Attempt |
3.2% |
Cardio-respiratory Arrest |
2.7% |
Poisoning |
2.7% |
Respiratory Depression |
2.7% |
Syncope |
2.7% |
Tremor |
2.7% |
Bradyphrenia |
2.3% |
|
Concomitant |
Drug Use For Unknown Indication |
27.3% |
Product Used For Unknown Indication |
15.8% |
Depression |
8.9% |
Pain |
8.0% |
Hypertension |
4.8% |
Hiv Infection |
4.1% |
Migraine |
3.4% |
Rheumatoid Arthritis |
3.2% |
Anxiety |
2.9% |
Multiple Sclerosis |
2.6% |
Multiple Myeloma |
2.5% |
Crohn's Disease |
2.1% |
Sleep Disorder |
2.1% |
Insomnia |
2.1% |
Headache |
1.9% |
Back Pain |
1.7% |
Gastrooesophageal Reflux Disease |
1.7% |
Bipolar Disorder |
1.7% |
Osteoporosis |
1.6% |
Nausea |
1.5% |
|
Weight Decreased |
13.6% |
Vomiting |
9.8% |
Weight Increased |
9.7% |
Nausea |
5.1% |
Type 2 Diabetes Mellitus |
5.1% |
Urinary Tract Infection |
5.1% |
Death |
4.8% |
Tremor |
4.8% |
Somnolence |
4.3% |
Pneumonia |
4.1% |
Alanine Aminotransferase Increased |
3.9% |
Pain |
3.9% |
Wrong Technique In Drug Usage Process |
3.9% |
Drug Ineffective |
3.6% |
Rash |
3.4% |
Pancreatitis |
3.3% |
Pruritus |
3.1% |
Tooth Extraction |
3.0% |
Thrombocytopenia |
2.8% |
Vision Blurred |
2.8% |
|
Interacting |
Hypertension |
21.8% |
Depression |
20.5% |
Drug Use For Unknown Indication |
16.7% |
Myofascial Pain Syndrome |
7.7% |
Abdominal Discomfort |
6.4% |
Hyperlipidaemia |
6.4% |
Asthma |
5.1% |
Anxiety |
2.6% |
Gastric Disorder |
2.6% |
Hypertonic Bladder |
2.6% |
Neuralgia |
2.6% |
Fibromyalgia |
1.3% |
Gastrooesophageal Reflux Disease |
1.3% |
Smoking Cessation Therapy |
1.3% |
Trigeminal Neuralgia |
1.3% |
|
Pyrexia |
35.0% |
Psychotic Disorder |
10.0% |
Drug Interaction |
5.0% |
Gastrooesophageal Reflux Disease |
5.0% |
Headache |
5.0% |
Hyperreflexia |
5.0% |
Hypertension |
5.0% |
Insomnia |
5.0% |
Palpitations |
5.0% |
Renal Impairment |
5.0% |
Serotonin Syndrome |
5.0% |
Tinnitus |
5.0% |
Weight Increased |
5.0% |
|